Researchers at UC San Diego School of Medicine have begun a pilot clinical trial to test the efficacy of using ultrasound to stimulate the spleen and reduce COVID-19-related inflammation, decreasing the length of hospital stays.

After a breast cancer diagnosis, Melinda Fletcher became the first patient at Ascension Saint Agnes to try scalp-cooling therapy.

10th Annual Bioelectronic Medicine Forum An Investment and Management Conference for Entrepreneurs and Executives April 13, 2027 This tenth annual meeting marks a decade as the premier management and investment conference for the bioelectronic medicine industry, a field that has moved from scientific promise to commercial reality since the first Forum convened. Attendees will have

Dignity Health and the Comprehensive Blood & Cancer Center highlighted an advancement in local cancer treatment Tuesday morning.

A LinkedIn post from Cooler Heads highlights recent legislative developments in California affecting coverage for scalp cooling treatments. According to the post, G…

Koya to participate in Goldman Sachs Healthcare Private Company Conference and The MedTech Conference, hosted by AdvaMed®

The new law will expand coverage of FDA-cleared scalp-cooling technology for some cancer patients starting Jan. 1.

Koya will hold private meetings at the BofA Healthcare Trailblazers Private Company Conference

The research pairs Mindera Health’s Dermal Biomarker Patch™ and Subtilitas Platform with Penn’s translational immunology expertise to decode quinacrine’s mechanism of action in treatment-resistant cutaneous lupus. Vista, CA, Sept. 09, 2026 (GLOBE NEWSWIRE) — Mindera Health™, a leader in precision medicine for dermatological conditions, today announced a research collaboration with the Perelman School of Medicine

Review published randomized comparative TEAYS data evaluating Dayspring versus advanced pneumatic compression in adults aged 65 and older and patients with phlebolymphedema.

Koya Medical has announced its participation in two investor conferences from June 2 to June 4, 2026

Decision brings precision medicine in psoriasis to all 50 states Vista, CA, April 22, 2026 (GLOBE NEWSWIRE) — Mindera Health, a leader in precision medicine for dermatological conditions, today announced it has received approval from the New York State Department of Health for its Mind.Px test. Mind.Px is a genomic test that utilizes the proprietary

The U.S. Food and Drug Administration (FDA) has granted Premarket Approval (PMA) to the  LimiFlex Dynamic Sagittal Tether , a motion-preserving system for the treatment of lumbar spinal stenosis associated with Grade I degenerative spondylolisthesis following decompression.

Vista, CA, March 18, 2026 (GLOBE NEWSWIRE) — Mindera Health, a leader in precision medicine for dermatological conditions, and Mountaineer Biosciences today announced the launch of Subtilitas, a precision translational medicine platform designed to bring objective, molecular-level insights into dermatology and immunology clinical research Subtilitas integrates non-invasive skin sampling, advanced molecular profiling, and artificial intelligence/machine